Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0001213900-25-015155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-14 | NMTC | MATHIESEN JEFFREY S | Dir | A - Grant | $0.00 | +27.8K | 114.4K | +32% | $0 |
| D | 2025-02-19 | 2025-02-14 | NMTC | MATHIESEN JEFFREY S | Dir | A - Grant | $0.00 | +17.0K | 17.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | A | A | 27,778 | $0.00 | 114,414 | D | — | — | (F1) Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. |
| 2 | Derivative | Option to Purchase Common Stock | 2025-02-14 | A | A | 17,025 | $0.00 | 17,025 | D | $1.20 · — to 2035-02-14 | 17,025 Common Stock | (F2) The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. |